Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to conduct a human trial of [C-11]OMAR, a new PET imaging
agent for the brain cannabinoid type 1 receptors (CB1), to determine its pharmacokinetics and
binding characteristics.